1. Home
  2. IRIX vs TRIB Comparison

IRIX vs TRIB Comparison

Compare IRIX & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$0.94

Market Cap

20.2M

Sector

Health Care

ML Signal

HOLD

TRIB

Trinity Biotech plc

HOLD

Current Price

$0.98

Market Cap

18.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRIX
TRIB
Founded
1989
1992
Country
United States
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.2M
18.3M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
IRIX
TRIB
Price
$0.94
$0.98
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
106.9K
55.3K
Earning Date
11-11-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,647,000.00
$61,555,000.00
Revenue This Year
$9.61
$13.51
Revenue Next Year
N/A
$13.14
P/E Ratio
N/A
N/A
Revenue Growth
4.58
8.31
52 Week Low
$0.78
$0.48
52 Week High
$1.90
$3.44

Technical Indicators

Market Signals
Indicator
IRIX
TRIB
Relative Strength Index (RSI) 44.46 50.30
Support Level $0.91 $0.95
Resistance Level $0.97 $0.94
Average True Range (ATR) 0.04 0.08
MACD 0.00 0.02
Stochastic Oscillator 44.72 64.29

Price Performance

Historical Comparison
IRIX
TRIB

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

Share on Social Networks: